sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Addictions Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00015265
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Addictions Therapeutics Market Analysis and Scope (2021-2031)

Buy Now

Addictions Therapeutics Market Report Addictions Therapeutics Market Size and Share Addictions Therapeutics Market Scope and Analysis

Addictions Therapeutics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 7.43 Billion
Market Size by 2031 US$ 14.49 Million
Global CAGR (2023 - 2031) 7.3%
Historical Data 2021-2023
Forecast period 2023-2031
Segments Covered By Treatment Type
  • Opioid Addiction Treatment
  • Alcohol Addiction treatment
  • Nicotine Addiction treatment
  • Other substance addiction treatment
By Drug Type
  • Nalaxone
  • Naltrexone
  • Bupropion
  • Disulfiram
  • Nicotine replacement products
  • Methadone
  • Varenicline
By Treatment Center
  • Inpatient treatment center
  • Residential treatment Center
  • Outpatient Treatment Center
By Distribution Channel
  • Hospital Pharmacies
  • Medical stores
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Indivior PLC
  • Pfizer Inc
  • GlaxoSmithKline Plc
  • Bausch Health Companies
  • Cipla Inc
  • Orexo AB
  • Purdue Pharma L P
  • Alvogen
  • Camurus AB
  • Hikma Pharmaceuticals Plc
    		•